144 related articles for article (PubMed ID: 27208691)
1. Role of HHV-8 and mTOR pathway in post-transplant Kaposi sarcoma staging.
Hernández-Sierra A; Rovira J; Petit A; Moya-Rull D; Mazuecos MA; Sánchez-Fructuoso AI; Errasti P; Idoate MÁ; Cruzado JM; Vidal A; Diekmann F; Oppenheimer F; Campistol JM; Revuelta I
Transpl Int; 2016 Sep; 29(9):1008-16. PubMed ID: 27208691
[TBL] [Abstract][Full Text] [Related]
2. mTOR, VEGF, PDGFR, and c-kit signaling pathway activation in Kaposi sarcoma.
Kerr DA; Busarla SVP; Gimbel DC; Sohani AR; Nazarian RM
Hum Pathol; 2017 Jul; 65():157-165. PubMed ID: 28506734
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus for Kaposi's sarcoma in renal-transplant recipients.
Stallone G; Schena A; Infante B; Di Paolo S; Loverre A; Maggio G; Ranieri E; Gesualdo L; Schena FP; Grandaliano G
N Engl J Med; 2005 Mar; 352(13):1317-23. PubMed ID: 15800227
[TBL] [Abstract][Full Text] [Related]
4. Human herpesvirus-8 infection and Kaposi's sarcoma after liver and kidney transplantation in different geographical areas of Spain.
García-Astudillo LA; Leyva-Cobián F
Transpl Immunol; 2006 Dec; 17(1):65-9. PubMed ID: 17157220
[TBL] [Abstract][Full Text] [Related]
5. Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF).
Farge D; Lebbé C; Marjanovic Z; Tuppin P; Mouquet C; Peraldi MN; Lang P; Hiesse C; Antoine C; Legendre C; Bedrossian J; Gagnadoux MF; Loirat C; Pellet C; Sheldon J; Golmard JL; Agbalika F; Schulz TF
Transplantation; 1999 May; 67(9):1236-42. PubMed ID: 10342315
[TBL] [Abstract][Full Text] [Related]
6. Post renal transplantation Kaposi's sarcoma: a review of its epidemiology, pathogenesis, diagnosis, clinical aspects, and therapy.
Hosseini-Moghaddam SM; Soleimanirahbar A; Mazzulli T; Rotstein C; Husain S
Transpl Infect Dis; 2012 Aug; 14(4):338-45. PubMed ID: 22316356
[TBL] [Abstract][Full Text] [Related]
7. Kaposi sarcoma in transplantation.
Lebbé C; Legendre C; Francès C
Transplant Rev (Orlando); 2008 Oct; 22(4):252-61. PubMed ID: 18656341
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression.
Stallone G; Infante B; Grandaliano G; Schena FP; Gesualdo L
Transpl Int; 2008 Sep; 21(9):825-32. PubMed ID: 18498314
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma in renal transplant recipients.
Zmonarski SC; Boratyńska M; Puziewicz-Zmonarska A; Kazimierczak K; Klinger M
Ann Transplant; 2005; 10(2):59-65. PubMed ID: 16218035
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients.
Andreoni M; Goletti D; Pezzotti P; Pozzetto A; Monini P; Sarmati L; Farchi F; Tisone G; Piazza A; Pisani F; Angelico M; Leone P; Citterio F; Ensoli B; Rezza G
J Infect; 2001 Oct; 43(3):195-9. PubMed ID: 11798259
[TBL] [Abstract][Full Text] [Related]
11. Outcome of kidney transplant recipients with previous human herpesvirus-8 infection.
Francès C; Mouquet C; Marcelin AG; Barete S; Agher R; Charron D; Benalia H; Dupin N; Piette JC; Bitker MO; Calvez V
Transplantation; 2000 May; 69(9):1776-9. PubMed ID: 10830210
[TBL] [Abstract][Full Text] [Related]
12. Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma.
Jham BC; Ma T; Hu J; Chaisuparat R; Friedman ER; Pandolfi PP; Schneider A; Sodhi A; Montaner S
PLoS One; 2011 Apr; 6(4):e19103. PubMed ID: 21559457
[TBL] [Abstract][Full Text] [Related]
13. Akt pathway protein expression in gastrointestinal Kaposi sarcomas: relevance for tumor biology.
Badescu A; Couvelard A; Handra-Luca A
APMIS; 2014 Jun; 122(6):518-25. PubMed ID: 24286304
[TBL] [Abstract][Full Text] [Related]
14. Outcome of second kidney transplantation in patients with previous post-transplantation Kaposi's sarcoma: A French retrospective study.
Bohelay G; Arzouk N; Lévy P; Rabaté C; Le Cleach L; Barete S; Barrou B; Matignon MB; Euvrard S; Lebbé C; Francès C;
Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28833536
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus-induced signaling modifications in Kaposi's sarcoma with resolution in a liver transplant recipient.
Ho CM; Huang SF; Hu RH; Ho MC; Wu YM; Lee PH
Clin Transplant; 2010; 24(1):127-32. PubMed ID: 19919613
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene.
Martin D; Nguyen Q; Molinolo A; Gutkind JS
Oncogene; 2014 May; 33(18):2405-12. PubMed ID: 23708663
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma in renal transplant patients: experience at the Cruces Hospital in Bilbao.
Mitxelena J; Gomez-Ullate P; Aguirre A; Rubio G; Lampreabe I; Díaz-Pérez JL
Int J Dermatol; 2003 Jan; 42(1):18-22. PubMed ID: 12581135
[TBL] [Abstract][Full Text] [Related]
18. Resolution of diffuse skin and systemic Kaposi's sarcoma in a renal transplant recipient after introduction of everolimus: a case report.
Detroyer D; Deraedt K; Schöffski P; Hauben E; Lagrou K; Naesens M; Delforge ML; Kuypers D
Transpl Infect Dis; 2015 Apr; 17(2):303-7. PubMed ID: 25645490
[TBL] [Abstract][Full Text] [Related]
19. Management of Kaposi sarcoma after solid organ transplantation: A European retrospective study.
Delyon J; Rabate C; Euvrard S; Harwood CA; Proby C; Güleç AT; Seçkin D; Del Marmol V; Bouwes-Bavinck JN; Ferrándiz-Pulido C; Ocampo MA; Barete S; Legendre C; Francès C; Porcher R; Lebbe C;
J Am Acad Dermatol; 2019 Aug; 81(2):448-455. PubMed ID: 30902727
[TBL] [Abstract][Full Text] [Related]
20. Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma.
Chaisuparat R; Hu J; Jham BC; Knight ZA; Shokat KM; Montaner S
Cancer Res; 2008 Oct; 68(20):8361-8. PubMed ID: 18922908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
